Lodoco 0.5 mg, Tabletten

7680699310012 CH-69931 Tabletten

Associated product:

LODOCO cpr 0.5 mg 30 pce

No image available

Article details

Package size
30
Selling units
30
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
colchicinum
0.5 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
88.87 MG Substance HBESI
gelatina
- Substance HNIDK
solani amylum
- Substance HNIDK
talcum
- Substance HNIDK
magnesii stearas
- Substance HNIDK

Authorization holder

AGEPHA PHARMA s.r.o., Bratislava,

6300 Zug

Authorization information

Swissmedic authorization number
69931
Drug name
Lodoco, Tabletten
Galenic form
TAB
ATC Code
M04AC01
Authorization status
Z
Dispensing category
A
First authorization
01/04/2026
Authorization expiration date
31/03/2031
IT Number
02.99.0.
Domain
Human medicine
Field of application
LODOCO ist indiziert, um das Risiko von Myokardinfarkt, Schlaganfall, koronarer Revaskularisation und kardiovaskulärem Tod bei erwachsenen Patienten mit etablierten atherosklerotischen Erkrankungen oder mit mehreren Risikofaktoren für kardiovaskuläre Erkrankungen zu verringern.

Package details

Description (FR)
LODOCO cpr 0.5 mg 30 pce
Description (DE)
LODOCO Tabl 0.5 mg 30 Stk
Market launch
01/04/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data